Gonadorelin
GnRH, Luteinizing Hormone-Releasing Hormone, LHRH, Factrel
A synthetic decapeptide analog of GnRH that stimulates the pituitary gland to release FSH and LH, aiding in reproductive hormone regulation and fertility treatments.
Completed
PHASE3
NCT01185704
Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
Merck KGaA, Darmstadt, Germany
INTERVENTIONAL
Updated Dec 15, 2025
Completed
EARLY PHASE1
NCT06778733
Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders
University of Athens
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT04178135
Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response
Reproductive & Genetic Hospital of CITIC-Xiangya
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT04050592
Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Hanna Savolainen-Peltonen
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE2
NCT03361735
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
City of Hope Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE1
NCT07097259
A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants
EMD Serono Research & Development Institute, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE2
NCT06145308
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Peking Union Medical College
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE2
NCT05568550
Pembro With Radiation With or Without Olaparib
Zin W Myint
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT03527823
The Comparison of Granulosa Cell Apoptosis Rates With or Without Luteinizing Hormone Administration in Poor Responders.
Sebnem Alanya Tosun
OBSERVATIONAL
Updated Dec 15, 2025
Unknown
PHASE2
NCT02935023
Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer
Shanghai Proton and Heavy Ion Center
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE1
NCT06379217
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
Novartis Pharmaceuticals
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00776074
A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.
Takeda
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT01634724
GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation
Nanjing University
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE4
NCT01816789
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
Andros Day Surgery Clinic
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06378268
PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)
Mỹ Đức Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01863680
Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel
Merck KGaA, Darmstadt, Germany
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00003124
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
Herbert Irving Comprehensive Cancer Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00254397
Melanoma Vaccine With Peptides and Leuprolide
M.D. Anderson Cancer Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT02036060
Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.
Spanish Oncology Genito-Urinary Group
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT03591549
Fulvestrant in Metastatic Breast Cancer
Assiut University
INTERVENTIONAL
Updated Dec 15, 2025